ロード中...
Recurrent BRAF kinase fusions in melanocytic tumors offer an opportunity for targeted therapy
BRAF is the most prevalent oncogene and an important therapeutic target in melanoma. In some cancers BRAF is activated by rearrangements that fuse its kinase domain to 5’ partner genes. We examined 848 comparative genomic hybridization profiles of melanocytic tumors and found copy number transitions...
保存先:
| 主要な著者: | , , , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3808507/ https://ncbi.nlm.nih.gov/pubmed/23890088 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/pcmr.12148 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|